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ABSTRACT
The auxiliary factor of U2 small nuclear ribonucle-
oprotein (U2AF) facilitates branch point (BP) recog-
nition and formation of lariat introns. The gene for
the 35-kD subunit of U2AF gives rise to two pro-
tein isoforms (termed U2AF35a and U2AF35b) that
are encoded by alternatively spliced exons 3 and
Ab, respectively. The splicing recognition sequences
of exon 3 are less favorable than exon Ab, yet
U2AF35a expression is higher than U2AF35b across
tissues. We show that U2AF35b repression is facil-
itated by weak, closely spaced BPs next to a long
polypyrimidine tract of exon Ab. Each BP lacked
canonical uridines at position -2 relative to the BP
adenines, with efficient U2 base-pairing interactions
predicted only for shifted registers reminiscent of
programmed ribosomal frameshifting. The BP clus-
ter was compensated by interactions involving un-
paired cytosines in an upstream, EvoFold-predicted
stem loop (termed ESL) that binds FUBP1/2. Exon
Ab inclusion correlated with predicted free energies
of mutant ESLs, suggesting that the ESL operates as
a conserved rheostat between long inverted repeats
upstream of each exon. The isoform-specific U2AF35
expression was U2AF65-dependent, required inter-
actions between the U2AF-homology motif (UHM)
and the 6 helix of U2AF35, and was fine-tuned
by exon Ab/3 variants. Finally, we identify tandem
homologous exons regulated by U2AF and show
that their preferential responses to U2AF65-related
proteins and SRSF3 are associated with unpaired
pre-mRNA segments upstream of U2AF-repressed
3′ss. These results provide new insights into tissue-
specific subfunctionalization of duplicated exons in
vertebrate evolution and expand the repertoire of
exon repression mechanisms that control alternative
splicing.
INTRODUCTION
U2AF is a stable heterodimer that facilitates recruit-
ment of the U2 small nuclear ribonucleoprotein (snRNP)
to the branch point (BP) (1–3). It consists of a 65-kD
subunit (U2AF65), which interacts with conserved, Y-
rich sequences upstream of 3′ splice sites (3′ss) known
as polypyrimidine tracts (PPTs) (2), and a 35-kD sub-
unit (U2AF35), which contacts almost invariant AG dinu-
cleotides at 3′ss and stabilizes U2AF65 binding (4–6). Each
U2AF subunit is essential for viability (7–10). Recent global
transcriptomic studies showed that the knockdown of hu-
man subunits affected preferentially alternative RNA splic-
ing and polyadenylation without widespread failure to rec-
ognize 3′ss of constitutive exons (11,12), consistent with
U2AF binding to a subset of 3′ss (11,13) and with its role in
transcription and gene termination (14–17). Depletion of
each subunit altered usage of U2AF-dependent exons al-
most exclusively in the same direction (11,12), in agreement
with their parallel requirements for 3′ss recognition in yeast
and their functional collaboration in vivo (10). U2AF35 can
self-interact (18) and knockdown of U2AF35 or overex-
pression of U2AF65 activated an identical cryptic 3′ss (19),
suggesting that stoichiometry of the two subunits is im-
portant for accurate 3′ss selection, but regulatory networks
that maintain their equilibrium in the cell are poorly under-
stood.
U2AF35 and U2AF65 are encoded by the U2AF1
and U2AF2 genes, respectively. Each gene is alternatively
spliced, giving rise to highly similar protein isoforms
(12,20). Alternative splicing of U2AF1 generates two iso-
forms (U2AF35a and U2AF35b) encoded by tandem 67-
nucleotide (nt) exons 3 and Ab (20) (Figure 1A). These ex-
ons arose by a duplication event that was followed by a
relatively minor divergence maintained throughout verte-
brate evolution (20). U2AF1 transcripts that include or ex-
clude both alternatively spliced exons contain stop codons
and are downregulated by nonsense-mediated RNA de-
cay (NMD) (12,20). Exons Ab and 3 encode a portion
of the UHM (21), introducing just seven amino acid vari-
ants located in the RNP2 motif, a short disordered re-
gion containing phosphoserines, and an unusually long -
helix, also known as helix A or 2 (22,23). The UHM in-
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Figure 1. U2AF1 exon Ab is repressed by the BP/PPT unit. (A) Alterna-
tive splicing of U2AF1 and schematics of the 4-exon reporter. Exons are
shown as boxes, introns as horizontal lines, spliced products (a, b, c, s) as
dotted lines, exon Ab/3 BPs as black circles and their PPT as hatched rect-
angles. The size of black circles represents a predicted BP strength; the
rectangle width denotes the length of PPT. Maximum entropy splice-site
scores are below each exon-intron junction. (B) Density of predicted splic-
ing enhancers in alternatively spliced U2AF1 exons. For abbreviations, see
Materials and Methods. (C) Regulation of alternative splicing of U2AF1
by Y-binding proteins. Spliced products of the 4-exon reporter digested
withHinfI, which cuts intron 1–exon 2 junction and exon Ab but not exon
3 (20), are shown to the right. Depleted proteins are at the bottom, im-
munoblots are in Supplementary Figures S1 and S2. sc, amixture of scram-
bled controls. HepG2 cells showed similar splicing patterns for each deple-
tion. (D and E) Mean inclusion levels of alternatively spliced mid-exons in
the mRNA. The 3-exon reporters are shown at the top, spliced products
to the right and siRNAs at the bottom. EI, exon inclusion, ES, exon skip-
ping. Error bars represent SDs of two transfections. Significant changes in
panels D–F, 2H and Figure 3C are denoted by asterisks (*P< 0.05, **P<
0.01, ***P < 0.001). (F) Schematic representation of permuted constructs
(left panel) and their exon inclusion levels in HEK293 cells (right panel).
Their sequences are in Supplementary Table S2.
teracts with the UHM ligand motif (ULM) of U2AF65
(21–23) and provides a scaffold for two highly conserved
C3H-type zinc finger domains (ZFs) that cooperatively bind
RNA (23). The C-terminal serine/arginine-rich (RS) do-
main of U2AF35 is less conserved and is separated from
ZF2 by a variable glycine linker (24,25). BothU2AF35a and
U2AF35b can form heterodimers with U2AF65 that rec-
ognize highly overlapping sets of 3′ss, but selective knock-
down of each isoform revealed transcripts and exons with
isoform-specific responses, suggesting that their function in
RNA processing is not equivalent (12,20,26). Moreover, al-
though the abundance of endogenous U2AF35a was higher
thanU2AF35b in several tissues (20), exogenous expression
of U2AF35a was lower than U2AF35b and endogenous
U2AF35b levels were dramatically increased uponU2AF65
knockdown (12). Despite a growing evidence for a distinct
function of U2AF35 proteins (12,20,26), molecular mech-
anisms leading to differential exon Ab/3 recognition have
remained unknown. Although multiple contacts were iden-
tified between theUHMandZFs in the yeastmodel (23), in-
teractions between the dimorphic UHM in vertebrates and
other U2AF35 domains are not fully understood.
Gene and exon duplications are principal events in evo-
lution (27–29). If a duplicated exon is recognized by the
spliceosome and introduces stop codons in the translational
reading frame, mRNA surveillance such as NMD gener-
ally downregulates transcripts with both exons, including
U2AF1 (12,20). This will increase the relative abundance of
transcripts containing either exon in the mRNA pool, forc-
ing the cell to explore their function following mutation-
driven diversification of duplicated regions. This process re-
quires efficient repression or activation of duplicated exon
copies, which can be achieved by steric interference, sec-
ondary structure, NMD or regulatory trans-acting factors
(reviewed in (30)), but there is little understanding of molec-
ular interactions between newly acquired mutations and
spliceosome components that eventually lead to develop-
mental stage-, environmental cue- or cell type-specific ex-
pression of new exons.
Here, we describe cis-acting elements and trans-acting
factors regulating alternatively spliced U2AF1 exons and
identify similarities between the ‘mutually exclusive’ splic-
ing ofU2AF1 and otherU2AF-dependent tandem exon du-
plications. We also demonstrate that the differential expres-
sion of U2AF35a and U2AF35b requires interactions be-
tween U2AF65 and the 2/6 helices of U2AF35.
MATERIALS AND METHODS
Cloning and mutagenesis
U2AF1 reporter constructs containing exons 2, Ab, 3 and
4 were cloned into pCR3.1 by ligating PCR amplicons 1–
3 (sized 655, 2075 and 274 nt) obtained with primers 1-F-
BamHI and 1-R, 2-F-XhoI and 2-R-ApaI, and 3-F and 3-
R-ApaI (Supplementary Table S1). Amplicons 1 and 3 con-
tained internal XhoI and XbaI sites, respectively (Figure
1A). The 3-exon U2AF1 minigenes (termed Ab and 3 ac-
cording to their central exon) were cloned by ligating frag-
ments amplified with primers PL4 (31) and 3Ea-XhoI or
PL3 (31) and 3Eb-XbaI to XhoI/ApaI- or BamHI/XbaI-
digested 4-exon constructs.
Wild-type U2AF35 and U2AF65 expression plasmids
(pCI-neo, Promega) had anN-terminalXpress tag (19). The
U2AF35 construct was insensitive to the small interfering
RNA (siRNA) U2AF35ab (19). Deletion constructs were
created by overlap extension PCR using the same vector. A
plasmid expressing FUBP1 (32) was a generous gift from
Dr Sylvie Tuffery-Giraud, INSERM.
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To create bicistronic constructs expressing various
U2AF1 segments, we prepared a green fluorescent pro-
tein (GFP)-expressing plasmid by inserting GFP into the
BamHI/NotI site of pcDNA3.1His/Xpress (Invitrogen).
The BglII/XbaI fragment of the plasmidDNAwas inserted
into the BglII/NheI site of pGL3-Luc (Promega). The lu-
ciferase (Luc) gene was removed together with the pGL3
SV40 promoter by a BglII/HpaI digest and replaced with
tested CMV-U2AF35-SV40late poly(A) cassettes from the
pCI-neo plasmids described above. For in vitro translation,
we employed pcDNA3.1-U2AF35a and -U2AF35b plas-
mids as described (19). The pcDNA3.1His/Xpress-GFP
was used to create hybrid ZF-GFP constructs for cotrans-
fection studies with the plasmid expressing U2AF65. Each
plasmid was propagated in Escherichia coli DH5α. Plasmid
DNA was extracted with the GeneJET Plasmid Miniprep
Kit (Thermo Scientific) and all plasmids were sequenced to
confirm mutations and exclude undesired changes.
Cell cultures, transfections and splicing assays
Human embryonic kidney (HEK) 293 cells were grown
as described (33). Transient transfections with plasmids
and siRNAs were performed with jetPRIME (Polyplus)
according to manufacturer’s recommendations. siRNAs
are listed in Supplementary Table S1 or were described
previously (19,33). Knockdown of heterogeneous nuclear
ribonucleoprotein C (hnRNP C) was achieved by the
HSS179304 siRNA (Invitrogen) (13). Cells were har-
vested 24–48 h after transfections with the indicated re-
porter constructs for RNA and western blot analyses. For
RNA stability measurements, DRB (5,6-dichloro-1--D-
ribofuranosylbenzimidazole; Sigma) and actinomycin D
(Sigma) were added at a final concentration of 20 and 7.5
g/ml, respectively, to replicates of HEK293 cell cultures
for the indicated time points. Total RNA was extracted
with TRI-reagent, treated with Turbo-DNase (Ambion)
and reverse transcribed with the M-MLV reverse transcrip-
tase (Promega) and the d(T)20VN primer. Exogenous tran-
scripts were amplified for up to 28 cycles using primers PL3
and PL4. PCR products were separated using agarose or
polyacrylamide gel electrophoresis and signal intensities of
RNA products were measured as described (34).
RNA pull-down assay
RNA pull-downs were carried out essentially as described
(35). Briefly, 500 pmols of synthetic 25-mers correspond-
ing to the wild-type ESL and its mutated version (Sup-
plementary Table S1) were treated with 5 mM sodium m-
periodate and bound to adipic acid dihydrazide agarose
beads (Sigma). Beads with bound RNAs were washed three
times in 2 ml of 2 M NaCl and three times in buffer D
(20 mM HEPES–KOH, pH 7, 6.5% v/v glycerol, 100 mM
KCl, 0.2 mM EDTA, 0.5 mM dithiothreitol), incubated
with HeLa nuclear extracts and buffer D with heparin at
a final concentration of 0.5 mg/ml. Unbound proteins were
washed five times with buffer D. Bound proteins were sepa-
rated on 10% sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE) or gradient NuPAGE 4–12%
gels, stained with the Coomassie blue and/or blotted on to
nitrocellulose membranes. Gel fragments specific for tested
RNAs were digested with trypsin and subjected to tandem
MS using a Bruker ultraflex III MALDI-TOF/TOF at the
Proteomic Technology Facility of the University of York.
Immunoblotting
Western blot analysis was carried out as described (19)
using antibodies against FUBP1 (GeneTex, GTX104579),
FUBP2 (also known as KHSRP or KSRP; Bethyl Lab-
oratories Inc., A302-021A-T), His-tag (Qiagen, 34660),
PTBP1 (36), SRSF3 (Sigma, WH0006428M8), TIA1 (Pro-
teintech, 12133-2-AP), TIAR (Cell Signaling Technology
Inc. D32D3), hnRNP E1/E2 (Sigma,R4155), MBNL1
(Sigma,M3320), DHX36 (ABcam, ab70269), CHEK2 (Cell
Signaling Technology Inc., D9C6), PUF60 and hnRNP
C (generous gifts from Professor Adrian Krainer, CSHL,
and Professor Gideon Dreyfuss, University of Pennsylva-
nia, respectively). Antibodies against U2AF35, U2AF65,
RBM39, Xpress and tubulin were described previously (12).
U2AF35 degradation pathways
Plasmids expressing U2AF35 isoforms (120 ng/ml) were
individually cotransfected with pGFP (50 ng/ml) into
HEK293 cells. The proteasome inhibitor MG132 (Sigma)
was added 36 hrs after plasmid transfections at a final
concentration of 10 M. Cell lysates were separated by
SDS-PAGE and immunoblots were successively incubated
with antibodies against the Xpress tag, U2AF35, GFP and
U2AF65. The lysosomal inhibitorNH4Cl was added to a fi-
nal concentration of 30 mM to HEK293 cells cotransfected
with U2AF35a or U2AF35b and U2AF65. Blots were in-
cubated with the Xpress antibody.
Cell-free U2AF35 synthesis
In vitro translation reactions were carried out using the
TNTR© Quick Coupled Transcription/Translation System
(Promega) according to the manufacturer’s recommenda-
tions. Twenty five microliter-reactions contained 20 l of
TNT Master Mix, 1 l of [35S]-methionine (1000 Ci/mmol
at 10mCi/ml), 50 ng of a control luciferase plasmid and 600
ng of plasmids expressing U2AF1 isoforms. Reactions were
incubated for 90 min at 30◦C and their aliquots were loaded
on to NuPAGE 4–12% Bis–Tris gels (Invitrogen). Gels were
dried and exposed to phosphorimager screens. Signal inten-
sity was measured with ImageQuant TL.
Branch point mapping
HEK293 cells were grown inDMEMwith orwithoutDBR1
siRNAs (Supplementary Table S1) and harvested 72 h af-
ter (mock) transfection for RNA extraction. The final con-
centration of each duplex was 40 nM. DBR1 encodes a
debranching enzyme that hydrolyzes 2′-5′ branched phos-
phodiester bonds, converting lariats into linear molecules
for degradation (37). A lack of debranching activity in vivo
leads to accumulation of excised lariat introns. Total RNA
was extracted using TRI-reagent and treated with DNase.
One microgram of purified RNA was reverse transcribed
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with the SuperScriptTM III cDNA synthesis kit (LifeTech-
nologies) and primer R1 (Supplementary Table S1). For
exon Ab, the first-strand cDNA was amplified with outer
primers F1 and R1 in the first round of PCR, which was
divided into multiple second rounds of PCR with inner
primers F2 and R2 (Supplementary Table S1). For exon 3,
we employed primers R1/F1-3 andR2/F2-3. Each step was
carried out at several annealing temperatures. Amplicons
were gel-purified, ligated into pGEM-T Easy (Promega)
and sequenced.
RNA-Seq data generated from cultures treated with or
without siRNAs targeting U2AF1 isoforms (ArrayExpress
accession number E-MTAB-2682) were searched for 15-
and 20-nt sequence strings at the 5′ss of U2AF1 intron 2
(three mismatches allowed). In addition, we analysed EN-
CODERNA-Seq data from 14 cell lines sequenced using Il-
lumina GA and GAII (38) and Illumina Body Map data of
16 different human tissues sequenced using Illumina HiSeq
2000.
Relative abundance of U2AF1 isoforms
We employed the FirstChoice human total RNA survey
panel with 20 different tissues, each containing a pool of
RNAs from different donors (LifeTechnologies). In ad-
dition, we used total RNA extracted from the indicated
cell lines. Rodent tissue samples were removed from iden-
tical organ locations (n = 7) of C57BL/6 mice and Wis-
tar, SHR24 and Sprague-Dawley rats. All animals were fe-
males aged 4 weeks at sampling. Animals were sacrificed
by cervical dislocation, conforming to regulations of a lo-
cal ethics committee. Organs were frozen immediately upon
collection in liquid nitrogen and stored at −80◦C for subse-
quent total RNA extraction. All RNA samples were reverse
transcribed using oligo-d(T) primers and complementary
DNAs were amplified with PCR primers described previ-
ously (20) for 26 cycles. Rat samples were amplified with a
reverse primer E6R (Supplementary Table S1).
Bioinformatic and statistical analyses
Densities of auxiliary splicing motifs previously defined as
FAS-ESSs (39), PESS/PESEs (40), RESCUE-ESEs (41),
putative SR proteins ESEs (42) and EIEs (43) were calcu-
lated as described (44). BPs were predicted using a support
vector machine (SVM) (45) or human-mouse (HM) com-
parison (46) algorithms. The PPT length was determined by
the SVM-BP tool (45). Maximum entropy splice-site scores
were calculated as described (47). RNA secondary struc-
tures were computed using phylogenetic stochastic context-
free grammar (48) and also mfold (49) and RNAbows (50)
to identify stable structures across conserved U2AF1 re-
gions. The PU (probability of unpaired) values were com-
puted as described (51) using human reference sequences
of the U2AF-regulated homologous exons (Table 1), their
flanking introns and additional 30 nt in each direction. De-
scriptive statistics and correlation coefficients were com-
puted using Stat200 (Biosoft, UK).
RESULTS
Positive and negative regulation of alternatively spliced
U2AF1 exons Ab and 3
U2AF1 exon Ab has a longer PPT than exon 3 (Figure 1A),
which has been associated with better recognition of verte-
brate exons (52,53), lacks splicing silencers and has a higher
density of splicing enhancers, including an excess of pre-
dicted binding sites for SR proteins such as SRSF1 (Fig-
ure 1B). The weaker 3′ss of exon 3 is not compensated by a
stronger 5′ss, yet exon Ab is included in theU2AF1mRNA
less efficiently than exon 3 (20). Why is the more optimal
exon Ab repressed in vivo?
To begin to answer this question, we first prepared a 4-
exon splicing reporter with exons Ab and 3 in the middle
(Figure 1A). Transfection of the wild-type construct into
HEK293 cells and visualization of exon Ab inclusion using
HinfI digests of spliced products confirmed the lower abun-
dance of U2AF1b than U2AF1a (Figure 1C), thus recapit-
ulating exon inclusion levels observed in vivo. As expected
for exogenous, ‘NMD-immune’ RNAs, minigene products
containing (U2AF1c) or lacking (U2AF1s) both exons were
more abundant than in endogenous transcripts (Figure 1C).
The extended PPT of exon Ab may bind other PPT-
binding proteins that compete with U2AF65 (13,54–56).
Transfection of this construct into cells individually de-
pleted of U2AF35, U2AF65 and a subset of Y-binding pro-
teins (Supplementary Figure S1) showed an increased rela-
tive abundance of U2AF1b in cells depleted of U2AF35 or
U2AF65 (Figure 1C, lanes 2–4). In contrast, knockdown of
a U2AF65-related protein PUF60 activated U2AF1a (lane
5) while hnRNP C depletion stimulated inclusion of both
exons (lane 7). Transfection of 3-exon minigenes with ex-
ons Ab or 3 in the middle confirmed that exon Ab was less
dependent on each U2AF subunit than exon 3 and was pro-
moted by PUF60 (Figure 1D and E). This exon was re-
pressed by hnRNP C, consistent with direct competition
between U2AF65 and hnRNP C (13), although exon 3 was
activated at higher siRNA concentrations (Supplementary
Figure S2).
To evaluate the extent to which PPTs and predicted BPs
contribute to inclusion levels of exon Ab and 3, we ex-
changed 47-nt segments (position −4 to −50) upstream of
their 3′ss in 3-exon minigenes and examined spliced prod-
ucts of the resulting hybrids (Figure 1F, Supplementary Ta-
ble S2). The BP/PPT of exon Ab placed upstream of exon
3 conferred exon skipping whereas the BP/PPT of exon 3
increased exon Ab inclusion.
We conclude that (i) the information required for exon
Ab repression is encoded by exon Ab and/or flanking in-
trons (Figure 1C, lane 2), (ii) the BP/PPT unit of exon 3 is a
more efficient exon activator than that of exon Ab, despite
a longer PPT of the latter (Figure 1A,F), (iii) the BP/PPT
of exon Ab is sufficient to inhibit its inclusion in the mRNA
(Figure 1F) and (iv) alternative splicing of U2AF1 is regu-
lated by its own product and other Y-binding proteins (Fig-
ure 1C–E).
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Table 1. 3′ splice site organization of U2AF-regulated tandem homologous exon
Gene Exon (isoform) U2AF-mediated Reference BP SVM score
PPT
lengtha AGEZ
FYNb,e 7a (FYNB) Repression Figure S20A,C 0.66 43 61
7b (FYNT) Activation Figure S20A,C 1.01 11 35
TPM1e 6a Activation (12) 1.21 6 104
6b Repression (12) 1.21 67 88
TPM2e 6a Activation (12) 2.34 16 34
6b Repression (12) 1.75 106 131
U2AF1e Ab (U2AF35b) Repression (or less efficient
activation)
Figure 1C–E Not predicted 25 31
3 (U2AF35a) Activation Figure 1C–E Not predicted 9 21
CALUc,e 3a Repression E-MTAB-2682d 1.39 27 48
3b Activation E-MTAB-2682 1.29 12 35
ACOX1 3a Activation E-MTAB-2682 0.98 19 24
3b Repression E-MTAB-2682 1.31 10 59
MAPK14e 9a Repression E-MTAB-2682 0.16 32 61
9b Activation E-MTAB-2682 −0.47 8 56
P4HA1e 10a Activation E-MTAB-2682 0.96 7 44
10b Repression E-MTAB-2682 1.03 22 26
aPPT length (nt) is for predicted BPs unless determined experimentally, as shown in Supplementary Figures S8 and S12.
cFYN exon 7a is a younger copy of exon 7b (118). These exons encode functionally distinct FYNT and FYNB proteins regulated by U2AF (summarized
in Supplementary Figure S20B).
cActivation of alternatively splicedCALU exon 3b (also known as exon 4) was associated with a promotion of distal transcription initiation site in HEK293
cells depleted of U2AF35 (Supplementary Figure S21).
dAccession number of RNA-Seq data for U2AF35 knockdowns.
eTranscripts containing Evofold-detected hairpins.
Identification of branch sites of alternative U2AF1 exons
To determine if the BP strength contributes to inclusion lev-
els of exonAb and 3, we first examined data from large-scale
BP mapping studies (57–59). They reported BPs for ∼20%
of human exons, but did not identify any BP of exonAb.We
next searched our own RNA-Seq data for samples depleted
of U2AF1a (12) for reads containing the 5′ end of intron
2 and lacking exon 2 ends, however, samples enriched for
U2AF1bwere not informative either. Prediction of exon Ab
BPs using HM (46) and SVM (45) algorithms produced dis-
tinct BP locations, each with at least one AG dinucleotide
in the AG exclusion zone (AGEZ) between the predicted
BP and 3′ss (Figure 2A). AGEZs contain the majority of
BPs (45,59), but AGs in AGEZs are selected by the splic-
ing machinery as 3′ss only if located >8–12 nt downstream
of genuine BPs (45,60,61), suggesting that the BP predic-
tions were incorrect. The AGEZ-filtered SVM prediction
produced only a low-confidence BP with a negative SVM
score (Figure 2A).
BP mapping in DBR1-depleted HEK293 cells (mock)-
transfected with the Ab minigene (Figure 2B) showed∼250
nt fragments in each culture (Figure 2C). Sequencing of 31
subclones revealed a cluster of four BP adenines close to
each other between position −40 and −30 relative to exon
Ab 3′ss, just upstream of the long PPT (Figure 2D and E).
No BPs had a canonical uridine at position −2 relative to
BP adenine (Figure 2A, D and E). BP at position −31 (BP-
31) had the highest number of predicted hydrogen bonds
with the BP-interacting region of U2 snRNA (Figure 2F)
although it was not used most frequently. Interestingly, pre-
dicted base-pairing interactions were much stronger when
the BP and surrounding sequences were shifted by 1 or 2
nucleotides (Figure 2G).
The weak BP cluster of exon Ab accommodates an un-
usual set of four AGs (underlined in Figure 2A). To test
their importance for exon Ab inclusion, we mutated each
AG in the Ab minigene. Mutations of the first and fourth
AG increased exon Ab inclusion, with an additive effect
for their combination, which was mirrored in cells lacking
U2AF35 (Figure 2H). The highest inclusion was found for
mutation of theAGmost proximal to the 3′ss, which created
an optimal BP consensusUNA-32 (62) next to BP-33. Elimi-
nation of the strongest BP-33 by the A>Gmutation and the
in situ improvement of the BP sequence consensus (muta-
tion −35G>T) had virtually no effect (Figure 1A and Sup-
plementary Figure S3), consistent with simultaneous recog-
nition of weak competing BPs that compensate each other.
To map BPs of exon 3, we employed primers for both
intron 2 and intron Ab since exon Ab is not a dominant
exon. Sequencing of a single product implicated adenines
−25 and −27, just downstream of a predicted BP (Supple-
mentary Figure S4), confirming the latter BP identified by
RNA-Seq (59).
Taken together, exon Ab has an atypical constellation
of weak, closely spaced BPs located immediately upstream
of its long PPT. None of these BPs were predicted com-
putationally and they all lacked the human UNA consen-
sus, suggesting that they require compensatory cis-elements
and/or trans-acting factors.
A conserved, FUBP1/2-boundmotif upstream of the BP clus-
ter regulates exon Ab
Both alternatively splicedU2AF1 exons are preceded by two
regions highly conserved in vertebrates, with a maximum
conservation at ∼100 nt and ∼500 nt upstream of their 3′ss
(Figure 3A). The 3′ region upstream of exon Ab accommo-
dates an EvoFold-detected (48) stem loop (termed ESL),
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Figure 2. U2AF1 exon Ab employs multiple noncanonical branch points. (A) Nucleotide sequence upstream of exon Ab. Predicted and experimentally
determined BPs are shown by open and closed circles, respectively. Boxes denote BP heptamers predicted using the support vector machine (SVM) (45) or
the comparative human-mouse (HM) (46) algorithms; a dotted box denotes a weak SVM BP heptamer (SVM score of −0.71) predicted with the AGEZ
filter. The distance relative to the 3′ss of exon Ab is shown at the bottom. Mutations introduced in the Ab reporter construct (Figure 1D) are in red at
the top. (B) Primers for BP mapping (Supplementary Table S1). (C) Lariat introns amplified from DBR1-depleted HEK293 cells mock-transfected (−) or
transfected (+) with the Ab reporter. (D) Sequence chromatograms of exon Ab lariats. Distances of BP adenines relative to the 3′ss are to the left. A black
rectangle denotes the 5′ end of U2AF1 intron 2. (E) Exon Ab BP usage in cells (mock)-transfected with the Ab reporter. (F) Predicted canonical base-
pairing interactions of each BP sequence with the U2 snRNA. The BP-interacting motif of U2 snRNA is boxed. The number of predicted hydrogen bonds
between the AUGAUG box of U2 and the pre-mRNA is to the right. The number of predicted hydrogen bonds between the pre-mRNA and extended
single-stranded region of U2 snRNA is in parentheses. (G) Predicted alternative base-pairing for each BP. Shifts of the U2 snRNA sequence towards the
5′ (−) or 3′ (+) intron ends are shown in parentheses to the left. Hydrogen bonds are numbered to the right as in panel F. (H) Exon inclusion levels of AG
mutants in U2AF35ab siRNA-treated (U2AF35-) and mock-treated (C) cells. Error bars denote SDs of duplicate transfections. Mutations are shown in
panel A.
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Figure 3. Internal loop of the predicted ultraconserved hairpin upstream of the BP cluster controls exon Ab inclusion. (A) Sequence conservation across
alternatively spliced U2AF1 exons Ab and 3. PhyloP conservation UCSC tracts are followed by the RefSeq annotation of U2AF1 exons (numbered at the
bottom). ESL (in green) is expanded in the lower panel; mutations are colored. ESL nucleotide positions are numbered according to their distance from the
3′ss of exonAb. Asterisk indicates an A>G substitution conserved inmany tetrapods (Supplementary Figure S5) and predicted to stabilize the hairpin. Red
horizontal bars at the top denote location of the longest inverted repeats (IR) in the conserved regions (Supplementary Figure S9). (B) Predicted free energies
(GESL) of the wild-type (WT) andmutant RNAs (kcal/mol). (C) Exon inclusion levels of ESL-mutated pre-mRNAs. Columns represent means and error
bars SDs of two transfections of the Ab reporter (Figure 1D). (D) RNA pull-down assay (upper panel) and immunoblots with the indicated antibodies
(lower panel). B, beads only, G-68, mutated synthetic RNA (Supplementary Table S1). AV3 and CD3 are control RNAs described previously (19,35). NE,
nuclear extract. CNBP (also known as ZNF9) is a CCHC-type zinc finger nucleic acid binding protein identified by mass spectrometry. (E) Exon inclusion
(%) in the mRNA from WT and mutated Ab constructs. Scrambled (SCR) and reverse complement (RC) sequences were gactacttttctacttacaggataa and
ttgcaaagagacaatttgtttgcaa, respectively. Their predicted energies (kcal/mol) and schematic secondary structures are as indicated. (F) Positive correlation
between predicted GESL and exon Ab inclusion levels of 11 different ESL reporters.
occupying positions −61 to −85 relative to the 3′ss (Fig-
ure 3A and Supplementary Figure S5). EvoFold employs
a stochastic context free grammar algorithm involving co-
variation to identify functional RNA structures (48). To test
the importance of ESL for exon Ab recognition, we intro-
duced a series of mutations in the Ab reporter predicted to
destabilize (7-nt deletion of the 5′ stem) or stabilize (C-68>G
and C-78>G substitutions) the hairpin or maintain self-
complementarity of the stem (a G−63C−64 swap, Figure 3B
and C). Transfections of mutated constructs into HEK293
cells revealed that the ESL stabilization diminished exon in-
clusion, indicating that exonAb is promoted by interactions
involving unpaired cytosines in the predicted internal loop.
RBPmap (63) predictions for ESL and flanking se-
quences suggested that the upper part of ESL may contain
binding sites for PTBP1, TRA2B and SRSF3 (Supplemen-
tary Figure S6), but tested mutations in putative PTBP1
(A−68) and TRA2B (G−76G−77) binding motifs had little
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effect on exon Ab splicing (Figure 3C). To identify proteins
that bind ESL, we carried out RNApull-down assays with a
synthetic wild-typeRNAand itsmutated version (C−68>G)
that reduced exon Ab inclusion (Figure 3C and D). Com-
parison of their binding patterns with control RNAs, fol-
lowed by mass spectrometry and immunoblotting, identi-
fied a specific interaction with the far-upstream element-
binding proteins 1 and 2 (FUBP1 andFUBP2). Overexpres-
sion and depletion of FUBP1 slightly reduced and increased
exonAb inclusion of the ESLG-68 mutants, respectively, but
a loop mutation changing one of the predicted binding sites
for FUBP1 (UU-73GU>UAGU) (64) had no effect (Sup-
plementary Figure S7).
To further test the role of ESL in exon Ab recognition,
we replaced the complete hairpin with its scrambled and
reverse complement versions in Ab minigenes (Figure 3E).
The scrambled formmaintained the same base composition
but introduced an unstable structure, thus addressing a pos-
sibility that the deletion of lower ESL stem (del-79–85 in Fig-
ure 3A–C) could still maintain intramolecular base-pairing
that fully support ligand interactions of the upper part. By
contrast, the reverse complement version was predicted to
maintain the overall structure while replacing the identity
of all unpaired residues. The former mutation significantly
increased exon Ab inclusion whereas the latter mutation re-
duced inclusion levels (Figure 3E), while further ESL hy-
perstabilization by mutation G−76G−68 yielded a similar ef-
fect (Supplementary Figure S7). Importantly, exon Ab in-
clusion levels and predicted free energies of our wild-type
andmutated constructs showed significant correlation (Fig-
ure 3F), arguing for a major role of ESL stabilities in regu-
lating exon Ab levels in vivo. The ESL importance was fur-
ther supported by a pair-wise alignment of exons Ab and
3 together with their upstream conserved regions, showing
a lack of both ESL and exon Ab BP sequences upstream
of exon 3 (Supplementary Figure S8), suggesting that these
motifs have not evolved independently.
In insects, mutually exclusive exon splicing has been
linked to conserved base-pairing interactions between
docking and selector sites adjacent to constitutive and vari-
ant exons (65,66). Interestingly, RNA secondary structure
predictions with conserved sequences upstream of exonsAb
and 3 revealed that formation of the most stable structures
consistently involved the longest inverted repeats in this re-
gion (Figure 3A and Supplementary Figure S9). These in-
verted repeats are of similar length and location to those im-
plicated inmutually exclusive splicing in insects (65,66), ten-
tatively looping out exon Ab and contributing to its repres-
sion. They are devoid of any natural DNA variants, which
are also absent in the ESL and the BP sequences of exon Ab
(Ensembl ENSG00000160201). Surprisingly, neither dele-
tions of their stem nor Ab/3 exon swaps of their central,
most stable portion in inverted (mutation 1 and 2) or direct
(mutation 3 and 4) orientations revealed any alterations of
exon inclusion levels in our reporters (Supplementary Fig-
ure S9).
We conclude that exon Ab usage is tightly controlled by
the ESL stability and that sufficient U2AF35b expression
requires interactions between unpaired ESL positions and
their ligands. The ESL is bound by FUBP1/2 that may po-
tentially help to enforce correct ESL folding through their
helicase activities.
Identification of exon cis-elements and SR proteins that con-
trol alternative splicing of U2AF1
To test if exonic variants contribute to exon Ab repression,
we examined splicing of exon Ab/3 hybrid reporters (Fig-
ure 4A and B; Supplementary Table S3). Exon Ab was most
promoted by exon 3 sequences that encode the U2AF35a
RNP2motif, as illustrated bymutationAb-2 (Figure 4B,C).
This Ab-to-3 swap changes glutamine 49 to leucine and cre-
ates a GAA trinucleotide, one of the most potent exonic
splicing enhancer (33,67,68). The remaining insertions of
exon 3 segments to exon Ab were closer to splice sites and
promoted exon skipping. Exon inclusion was also slightly
improved by introducing the exon Ab-specific HinfI site in
the equivalent position of exon 3.
To identify additional trans-acting factors that regulate
alternatively spliced exons Ab and 3, we individually de-
pleted HEK293 cells of a subset of SR proteins, well-known
splicing regulators (69), and examined the splicing pat-
tern of 4-exon minigenes. Depletion of SRSF3 and co-
depletion of Tra2 and Tra2 promoted U2AF1b, with
SRSF3 knockdown dramatically stimulating U2AF35c
(Figure 4D and E). In contrast, a lack of SRSF7 increased
U2AF1a. SRSF1 knockdown did not significantly alter the
U2AF1a/bmRNA ratio (data not shown). In cells depleted
of Tra2 proteins, exon 3 was preferentially skipped. The
same direction of exon Ab/3 usage was observed for en-
dogenous U2AF1 (except for isoforms targeted by NMD),
with a significant correlation ofU2AF1b/U2AF1a ratios be-
tween endogenous and exogenous transcripts (r= 0.66;P<
0.01).
Identification of U2AF-regulated tandem exons controlled by
SRSF3
Examination of our RNA-Seq data (12) for altered usage
of mutually exclusive tandem homologous exons (listed in
(70)) revealed a set of 8 exon pairs responsive to U2AF35
knockdown, in which one homolog was activated and the
other was repressed (Table 1). To test their functional and
structural similarities to exon Ab/3, we first examined their
usage in independent depletions of each U2AF subunit,
U2AF-related paralogs and other Y-binding proteins, in-
cluding SRSF3. This analysis confirmed the antagonism of
U2AF and PUF60 and the synergism between U2AF and
RBM39 (Supplementary Figure S10A-D) (12), both pro-
teins structurally related to U2AF65 (21). Interestingly, it
also revealed that in most cases, the SRSF3 knockdown in-
creased the relative abundance of transcripts that contained
both homologous exons (Supplementary Figure S10B), in-
dicating that in most pairs, SRSF3 is required for repres-
sion of a single homolog. Unlike other SR proteins, SRSF3
binding sites are Y-rich, with a core CNUC motif (71,72),
suggesting that the functional affinity of U2AF-dependent
exon homologs for SRSF3 could be explained by RNA
binding. Examination of published ultraviolet crosslinking
and immunoprecipitation (CLIP) data for Srsf3 and other
SR proteins (71,72) revealed significant binding to U2af1
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Figure 4. Identification of exonic variants that influence inclusion of alternative U2AF1 exons. (A) Sequence differences between alternatively spliced
U2AF1 exons and U2AF35 isoforms. Amino acids are numbered at the bottom. Exon 3 segments introduced in exon Ab (numbered at the top) are
highlighted in gray; the HinfI site is boxed. Homologous residues that interact with S43 of the U2AF35 ZF1 and K169 of the U2AF35 ZF2 in the yeast
model (23) are circled. (B) Schematics of permuted middle exons in minigene Ab (black) and 3 (gray). Their full sequences are in Supplementary Table
S3. (C) Exon inclusion levels of reporters shown in panel (B). (D) Splicing pattern of exogenous U2AF1 transcripts in cells lacking the indicated SR(-like)
proteins. Concentrations of siRNAs were as described (19). Ctr, control siRNA. Designation of U2AF1 mRNA isoforms is as in Figure 1. (E) Isoform
quantification for panel D. Error bars are SDs of two transfections.
exons Ab/3 as well as other homologous exon pairs. How-
ever, the Srsf3 CLIP tags did not extend into exon Ab BPs
or ESL, although they were mapped to the BP/PPT of
the U2AF-activated exon 3 (Supplementary Figure S10E).
Nevertheless, the Srsf3 crosslinking events were present also
near BPs of a U2AF-repressed exon in Tpm1. Taken to-
gether, U2AF-regulated duplicated exons showed preferen-
tial responses to Y-binding proteins SRSF3, PUF60 and
RBM39.
Organization of U2AF-regulated 3′ splice sites of duplicated
exons
The majority of invertebrate tandem exon duplications as-
sociated with mutually exclusive splicing resulted from ho-
mologous recombination (HR) events that engaged the up-
stream intron in each case (73). AHR-mediated duplication
of the U2AF1 intron 2–exon 3 segment (Figure 5A) would
also explain the mutually exclusive splicing of exons Ab and
3 as well as the existence of the two regions of vertebrate
conservation, which are located at a similar distance from
their 3′ss (Figure 3A) and share significant sequence iden-
tity (Supplementary Figure S8). Although the least diverged
exonic sequence encoding the almost invariant YRNPQN
motif of the UHM (Figure 5B) may also constitute a fa-
vorable HR crossover region, the two exons share the 5′ss
consensus (Supplementary Figure S8), arguing for a HR
breakpoint further downstream. Importantly, comparison
of duplicated exon pairs (Table 1) showed that exons acti-
vated by U2AF had invariably shorter PPTs than U2AF-
repressed exons (or less efficiently activated, as in U2AF1;
Figure 5C). To test if the differential PPT length alters
their overall capacity for ligand interactions, we examined
their base-pairing potential by computing PU (probability
of unpaired) values, which estimate RNA singlestranded-
ness using the equilibrium partition function (51). Most in-
tronic positions upstream of 3′ss of U2AF-repressed ho-
mologous exons exhibited significantly higher PU values
than those upstream ofU2AF-activated counterparts (Sup-
plementary Figure S11A). Their mean was even higher than
that reported for experimentally determined intronic splic-
ing regulatory motifs (Table 2; 0.387 versus 0.351 in (51)) or
for all U2AF-repressed exons identified globally (12). The
higher probability of unpaired interactions was associated
with an excess of pyrimidines and depletion of purines, par-
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Figure 5. A role for BP/PPT interactions in subfunctionalization of tan-
dem homologous exons. (A) BP/PPT ligands as repressors of duplicated
exons. For BP/PPT symbols, see legend to Figure 1A. Ancestral and
replica exons are denoted by gray boxes; flanking exons by white boxes;
duplicated DNA segments by gray rectangles below; a repressed exon
homolog by a black box; splicing by dotted lines. Exon-inhibiting and -
stimulating motifs or splicing factors are shown in red and green, respec-
tively. Red arrow signifies competition between U2AF and other PPT lig-
ands (L), which may also bind U2 snRNP components, thus inhibiting U2
binding to the BP (black vertical arrows). (B) Pictogram representation of
protein sequences encoded by exons Ab and 3 from 12 species, ranging
from D. melanogaster to H. sapiens. Exon positions are numbered at the
bottom. (C) Average PPT/AGEZ length and SVM BP scores of U2AF-
responsive tandem exon homologs. Two-tailed P-values (t-test) are shown
at the top.
Table 2. Mean PU values for U2AF-repressed and -activated duplicated
homologous exons
Upstream of 3′ssa Downstream of 5′ssa
U2AF-repressed exons 0.387 0.177
U2AF-activated exons 0.146 0.194
P-value P <10−16 P > 0.1
aMean PU values were calculated by averaging position-specific values
computed for human genomic reference sequences (hg19) in segments
shown in Supplementary Figure S10A and B. P-values were obtained by
comparing mean PU values for U2AF-repressed and -activated tandem
exons with the Wilcoxon–Mann–Whitney test.
ticularly cytosine and guanine, respectively (Supplementary
Figure S11B). In contrast, the first ∼10 positions of the
exon tended to bemore single-stranded forU2AF-activated
exons (Supplementary Figure S11C) while the PU values
downstream were similar (Table 2, Supplementary Figure
S11D).
DNA mutability generally increases with the length of
single- or di-nucleotide runs, leading to diversification over
time and shortening of uninterrupted repeats (74,75). In
an attempt to capture these evolutionary events in PPTs
of U2AF-regulated exon pairs, we aligned their sequences
together with their upstream introns, revealing frequent
insertions/deletions (indels) in their BP/PPT units (Supple-
mentary Figures S8 and S12). In U2AF1, neither the BP
cluster of exon Ab nor the ESL had a paralog upstream of
exon 3 (Supplementary Figure S8). In P4HA1 (Supplemen-
tary Figure S12), a motif containing a previously mapped
BP (59) was upstream of the U2AF-repressed exon 10b but
not exon 10a. InTPM1, mutations or insertions of adenine-
lacking sequences moved the BP of exon 6b upstream. Di-
versification upstream of TPM2 exons by indels would shift
BP paralogs further upstream of the U2AF-repressed exon
6b, creating a weak distant BP cluster. Indels that remove or
create BPs and extend or shorten PPT were observed also
upstream of homologous FYN, ACOX1 and MAPK14 ex-
ons (Supplementary Figure S12).
Collectively, these observations suggest that a lack of
U2AF allows the competing ligand(s) (L in Figure 5A) to
access longer and more accessible PPTs to activate the first
downstream exon and repress its homolog with a shorter
PPT. They also suggest that indels involving BP/PPT units
played an important role in subfunctionalization of protein
isoforms encoded by mutually exclusive exons.
Tissue-specificity of human U2AF1 isoforms
Subfunctionalization often involves tissue-specific expres-
sion of transcripts carrying either exon of the homologous
pair (20,76), however, tissue distribution of humanU2AF35
isoforms is not known. We determined the relative abun-
dance of each isoform in 20 tissues, quantifiedU2AF35 pro-
teins on immunoblots from a panel of cell lines, analyzed
RNA-Seq data from 16 human tissues and additional 14 cell
lines, and compared their variability in 7 tissues obtained
from five rodents (Supplementary Figure S13A–D). The
relative abundance of U2AF1b was lower than U2AF1a in
all human tissues examined (Supplementary Figure S13A).
The analysis of variance of exon inclusion levels showed
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that the variability between rodent tissues was significantly
higher than variability between strains or species (Supple-
mentary Figure S13B), providing the evidence for minor
tissue-specific differences. The lowest expression of both
rodent and human U2AF1b was found in liver, consistent
with the Illumina Body Map RNA-Seq data (Supplemen-
tary Figure S13A,B,D). Finally, immunoblotting revealed
several heteroploid cell lines, in which U2AF35b was more
abundant than U2AF35a (Supplementary Figure S13C).
Isoform-specific expression of U2AF35 is U2AF65-
dependent
U2AF65 knockdown downregulated U2AF35 (12,77)
and increased the U2AF35b/U2AF35a ratio, which was
not accompanied by a corresponding increase in the
U2AF1b/U2AF1a mRNA ratio (12). Following expo-
sure to RNA synthesis inhibitors 5,6-dichloro-1--D-
ribofuranosylbenzimidazole and actinomycin D, we ob-
served a similar mRNA decay of U2AF1a and U2AF1b
for up to 8 hrs post-treatment (Supplementary Figure
S14). Overexpression of exogenousU2AF35 resistant to the
U2AF35-specific siRNA (12,19,77) was higher in siRNA-
treated than untreated cells (Figure 6A, lanes 1–2), sug-
gesting that free endogenous U2AF65 can enhance exoge-
nous U2AF35 expression. This increase was found also
for constructs lacking the U2AF35 RS domain (lanes 3–
4). U2AF35 knockdown was associated with the enhanced
degradation of U2AF65 (Supplementary Figure S15), pos-
sibly through caspase activation (78), which could ex-
plain the observed compensatory increase of U2AF2 mR-
NAs in depleted cells (12). Expression of U2AF35a and
U2AF35b constructs was also increased upon cotransfec-
tion with wild-type U2AF65 plasmids into untreated cells
(cf. lanes 1 versus 2 and 4 versus 5, Figure 6B). Impor-
tantly, the U2AF65-mediated enhancement was diminished
with U2AF65 constructs mutated in residues that contact
U2AF35 (W92, Y107; (22)) as compared to the wild-type
U2AF65 (lanes 2 versus 3 and 5 versus 6). The failure of
mutated U2AF65 to efficiently augment the signal from
U2AF35 proteins was confirmed in independent transfec-
tions with increasing amounts of U2AF65 plasmids (Sup-
plementary Figure S16).
The higher expression of U2AF35b than U2AF35a (Fig-
ure 6B, lanes 1–3 versus 4–6) (12) could be due to a
higher resistance of U2AF35b to degradation, but the
U2AF35 degradation pathway is unknown. Overexpression
of U2AF35a or U2AF35b in HEK293 cells prior to their
exposure to proteasome inhibitor MG132 or lysosomal in-
hibitor NH4Cl (Figure 6C and D) showed an increased sig-
nal intensity from both U2AF35a and U2AF35b in cells
treated with MG132 for 24 h (Figure 6C, lanes 5, 6 versus
7, 8). Taken together, these results indicate that the isoform-
specific expression of U2AF35 is U2AF65-dependent and
degradation of eachU2AF35 protein is at least partiallyme-
diated by the proteasome.
The role of U2AF35 domains in isoform-dependent expres-
sion
Amino acid differences between U2AF35a and U2AF35b
are limited to the UHM (Figure 4A). To determine if this
domain alone is sufficient for differential stabilization by
U2AF65, we cotransfected plasmids expressing only the
U2AF35a orU2AF35bUHMwith the correspondingwild-
type U2AF35 isoform and varying amounts of U2AF65.
Surprisingly, contrary to the full-length constructs, the sig-
nal from exogenous UHMa and UHMb was similar (Fig-
ure 7A). To identify responsible U2AF35 domains, we co-
transfected HEK293 cells with the wild-type U2AF65 ex-
pression plasmid and U2AF35a- and U2AF35b-derived,
Xpress-tagged deletion constructs (Figure 7B, Supplemen-
tary Figure S17). Immunoblotting revealed the highest ex-
pression from constructs preserving the 6 helix and lack-
ing ZF1 (Figure 7C and D). In a recent crystal structure of
the S. pombe ortholog, the 6 helix provides additional con-
tacts with the large subunit and runs in parallel with the 2
helix (23), which differs between vertebrate U2AF35a and
U2AF35b (20,22). In contrast to 6, which enhanced the
signal from each isoform (lanes 3 versus 4, 5 versus 6, Fig-
ure 7C and D), addition of ZF1 diminished their expres-
sion (lanes 3 versus 5 and 4 versus 6). To validate these re-
sults, we transfected isoform-specific bicistronic constructs
expressing GFP and U2AF35 domains into HEK293 cells.
Comparison of 6-containing or -lacking plasmids con-
firmed the higher expression of U2AF35b over U2AF35a
in the former constructs, but not in the latter (Figure 7E
and F). The same observation was made for their mono-
cistronic counterparts in the presence of increasing con-
centrations of exogenous U2AF65 (Supplementary Figure
S18). In contrast, wild-type U2AF35a and U2AF35b plas-
mids produced similar protein yields in cell-free reticulocyte
lysates (Figure 7B, G and H). Finally, to confirm the ef-
fect of individual U2AF35 ZFs on other peptides, we fused
each ZF with GFP and transfected the resulting hybrids
into HEK293 cells. The GFP signal was diminished by the
N-terminally expressedZF1while ZF2 reduced theGFP ex-
pression to a lesser extent (Figure 7I, Supplementary Figure
S19).
In conclusion, the differential expression of U2AF35a
and U2AF35b requires interactions between the dimorphic
UHM and the 6 helix of U2AF35, most likely through
conserved 2/6 contacts with the U2AF65ULM. Expres-
sion of each U2AF35 protein is also dictated by their ZFs.
DISCUSSION
U2AF35 isoforms are important for accurate 3′ss recog-
nition (12,20) but their regulation and function in the cell
have been obscure. We have first shown that repression of
U2AF35b in vivo is facilitated by the unusual 3′ss organiza-
tion of U2AF1 exon Ab, with weak multiple BPs immedi-
ately upstream of its long PPT. Multiple BPs were initially
identified for a small number of cellular and viral exons (79–
82), but recent RNA-Seq studies suggested that ∼9–32%
exons have multiple BPs, up to 11 distinct BPs per exon
(57,59). Multiple BPs often cluster in close proximity to
each other and are not equally used (59), in agreement with
BPs of exon Ab (Figure 2). Exon Ab BPs were not revealed
by computational predictions, illustrating their limited ac-
curacy (estimated at ∼75% for the best algorithm (45)). We
observed typical A>T substitutions at the 2′-5′ phosphodi-
ester bond (Figure 2D, Supplementary Figure S4C), which
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Figure 6. Differential U2AF35a and U2AF35b expression is U2AF65-dependent. (A) Increased expression of exogenous U2AF35 by free endogenous
U2AF65 (enU2AF65). Concentration of the U2AF35 siRNA and plasmids was 30 nM and 200 ng/ml, respectively. Blots were incubated with antibod-
ies against U2AF35 and U2AF65. Knockdown of U2AF35 was associated with a higher mobility U2AF65 fragment (Supplementary Figure S15). (B)
U2AF35a and U2AF35b expression depends on their interaction with U2AF65. HEK293 cells were transfected with the indicated Xpress-tagged plas-
mids and harvested after 48 h. Final concentration of U2AF35 and U2AF65 plasmid DNA in culture media was 130 and 70 ng/ml, respectively. Blots
were sequentially exposed to Xpress, U2AF35 and -actin antibodies. (C and D) Exogenous U2AF35 isoforms are degraded by the proteasome. Blots
were successively incubated with antibodies against Xpress (exU2AF35), U2AF35 (enU2AF35), GFP and U2AF65 (enU2AF65 and degU2AF65) (C).
A C-terminal degradation product of U2AF65 was described previously in Jurkat cells (78). U2AF expression following addition of lysosomal inhibitor
NH4Cl and immunoblotting with the Xpress antibody (D).
are diagnostic of BPs (57,59), but we have not obtained any
amplicons indicative of more distant BPs using additional
forward primers nearer exon 2 (Figure 2B, Supplementary
Figure S4A). BPs of exon Ab and 3 were just upstream of
their PPTs (Figure 2A), the arrangement associated with a
maximum efficiency of lariat formation (83).
Each BP sequence of exon Ab lacked pyrimidine at posi-
tion BP-2 (Figure 2A,D), which is the most conserved site
flanking the BP adenine (59) and a hot-spot for substitu-
tions leading to genetic disease (84). How are such weak
BPs recognized? In yeasts, mutations of BP-2U alter the re-
lease of Prp5 from U2, block tri-snRNP association and
impair folding of the BP-interacting stem-loop in U2, but
do not appear to prevent prespliceosomal formation (85).
Apart from auxiliary splicing elements (86), such weak BPs
may require enhanced base-pairing with U2, as originally
proposed for GH1 (87). Extending base-pairing contacts
between U2 and upstream BP sequences improved splic-
ing of the BP-2U>C mutant (88) and bulged adenosines
placed at position +1 or −1 relative to canonical position
participated in the first-step splicing catalysis (89). Rever-
sal of the orientation of a base pair switch AU2-Uintron to
UU2-Aintron resulted in a stacked intrahelical position of the
BP adenine and reduced splicing efficiency (90,91), consis-
tent with the importance of nucleophile bulging for splic-
ing (89). The flexibility in nucleophile specification observed
in yeast is likely to be even higher for more relaxed mam-
malian BPs. The number of hydrogen bonds predicted be-
tween the weak BPs of exon Ab and U2 snRNA was more
than doubled when base-pairing registers of the extended
single-stranded regions of U2 were shifted (Figure 2F and
G), similar to unusual BPs in GH1 (87). Thus, future stud-
ies of noncanonical BPs should confirm if they can be com-
pensated by shifted or ‘bulged’ registers, as was shown for
U1 interactions with the 5′ss (92). Bulged 5′ss were prefer-
entially alternatively spliced, but their fraction estimated at
∼5% (92) is even lower than that of noncanonical BPs (59).
Putative shifts in base-pairing interactions between U2 and
weak BPs (Figure 2F and G) or between U2 and 5′ss (92)
are also reminiscent of translational frameshifting, which
alters kinetic partitioning rates between in-frame and out-
of-frame codons at ‘slippery’ sites (93).
The weak BPs of exon Ab could be offset by interac-
tions involving unpaired ESL residues (Figure 3). A grow-
ing number of hairpins at or near BPs have been reported
to affect 3′ss usage (94–101). In GH1, the stem-loop stabili-
ties correlated with 3′ss utilization (95), similar to ESL (Fig-
ure 3F) and other stem loops (33 and refs. therein). Human
introns contain >10 000 of EvoFold-detected structures,
with many acting as miRNAs (48), but no miRNA precur-
sors have been described inU2AF1 (www.mirbase.org). The
EvoFold algorithm should thus help identify novel splicing
regulatorymotifs inmany genes, including those containing
tandem exons (Table 1). The U2AF1 ESL could provide a
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Figure 7. The role of U2AF35 domains in isoform-dependent expres-
sion. (A) UHM domains alone are not sufficient for differential expres-
sion of full-length U2AF35 isoforms. HEK293 cells were transfected with
constant amounts of 1:1 mixtures of the wild-type and UHM U2AF35a
plasmids or the wild-type and UHM U2AF35b plasmids. The plasmids
were supplemented with varying ratios of U2AF65/U2AF65dRS plas-
mids (150, 50, 15 and 0/0, 100, 135 and 150 ng). The U2AF65RS plas-
mid was used as a transfection control and to formally exclude that the
U2AF65 RS domain can affect the isoform-specific expression through
additional contacts with U2AF35. MG132 or DMSO was added 36 hrs
later. Immunoblots were incubated with the Xpress antibody, which de-
tects the N-terminal part (∼25 kD) of U2AF65deg (degradation prod-
uct of U2AF65). U2AF35a was visible only in MG132-treated cells. (B)
Summary of U2AF35 deletion constructs. Their alignments are in Supple-
mentary Figure S17. The 6 helix (residues 179–194) is denoted by . (C
and D) The importance of U2AF35 domains for expression of U2AF35a
(C) and U2AF35b (D). The deletion plasmids or empty vectors (EV) were
cotransfected with constant amounts of wild-type U2AF65 and UHM-
only U2AF35 constructs (150 ng/ml each); membranes were incubated
with the Xpress antibody. Plasmid symbols correspond to those in panel
(B). (E) The 6 helix of U2AF35 is necessary for differential expression of
U2AF35a and U2AF35b. Concentration of the indicated bicistronic vec-
tors (B.c.) was 150 ng/ml. Cell lysates (40, 20 and 10 g for constructs
lacking 6 and 30, 15 and 7.5 g for constructs containing 6) were incu-
bated withU2AF35 andHis antibodies. (F) Signal intensities measured for
panel (E). Error bars indicate SDs. (G) Cell-free translation of wild-type
scaffold to support U2 binding to the weak BPs through in-
teractions involving C−68/C−78 (Figure 3A–C) or promote
early BP interactions, as reported for a hairpin that im-
proved binding of the branch-point binding protein (102). It
might also act as a kinetic trap for base-pairing shifts, sim-
ilar to hairpins adjacent to the translational slippery sites
(93). ESL–FUBP1/2 interactions (Figure 3D) could pre-
vent misfolding of alternative structures as FUBP1 knock-
down and overexpression appeared to differentially affect
inclusion of exon Ab in mutant minigenes (Supplementary
Figure S7), but interacting residues remain to be defined.
Both FUBP proteins were previously implicated in pre-
mRNA splicing (103,104). Together with U2AF65, FUBP1
was identified in amultiprotein complex bound upstream of
Tpm2 exon 6b (104), bound a splicing enhancer upstream of
DMD exon 39 (32) and a cryptic exon in ATM (105). Im-
portantly, FUBP1 interacts with PUF60 (106) and SRSF3
(107), which both control exon Ab usage (Figure 1C,D).
The ‘mutually exclusive’ character of U2AF1 exons Ab
and 3 is typical of alternative splicing of duplicated exons,
which are present in >10% of human genes (29). Our data
suggest that mutation-driven changes in the BP/PPT orga-
nization contribute significantly to the evolution of U2AF-
regulated tandem exons (Figure 5, Supplementary Figures
S8, S10 and S11). Recent RNA-Seq studies showed that
deletions upstream of proto-exons favored their creation or
maintenance, despite low exonic enhancer densities (108).
Longer (>11 nt), U-rich PPTs are preferentially bound
by PUF60 (109), but binding preferences of the U2AF-
interacting RBM39 (110) remain to be characterized. Each
C-terminal UHM in U2AF65, RBP39 and PUF60 (21) can
interact with a key U2 snRNP protein SF3B1 (111–115).
The U2AF65 UHM can potentially interact with SF3B1 at
multiple sites that have distinct binding affinities and muta-
tions of high-affinity sites repressed splicing (112), suggest-
ing that these interactions may compensate weak BPs. In-
terestingly, cancer-associated SF3B1 mutations have been
recently linked to selection of aberrant upstream BP/PPT
units that have shorter PPTs (116).
The PPT signal gradually strengthened in metazoan evo-
lution, with progressive cytosine enrichment from inverte-
brates to mammals (117), highlighting the importance of
cytosine-binding PPT ligands in organisms with high levels
of alternative splicing. For example, several fungi lack PPTs
altogether and have extended BP consensus while PPTs in
zebrafish, which lacks alternatively spliced U2AF1 exons
(Ensembl ENSDARG00000015325), show no cytosine en-
richment (117). Longer PPTs in humans have been associ-
ated with exon repression by PTBP1 (36) and long U-tracts
with major changes in U2AF65 binding upon depletion of
hnRNP C (13). Depletion of other candidate exon repres-
sors that bind Y-rich RNAs, including or MBNL1, TIA1
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
U2AF35a and U2AF35b constructs. Luc-expressing plasmid was used as
a control. (H) Signal intensities for panel (G). Error bars indicate SDs for
two independently cloned and sequence-verified plasmids separately trans-
lated in vitro. (I) U2AF35 ZF domains reduce expression of the C-terminal
GFP. Expression of the ZF1-GFP constructs could be visualized only af-
ter incubation with MG132 (right panel). Blots were incubated with the
Xpress antibody.
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and TIAR, suggested that they may have a more limited
and less predictable effect on the U2AF-regulated exon ho-
mologs (Supplementary Figure S10C), in agreement with a
lack of TIA1/TIARCLIP tags atU2AF65/hnRNPCbind-
ing sites (13). PPT-binding proteins could also contribute
to the low exon Ab expression in the liver (Supplementary
Figure S13); for example, PUF60 promotes exon Ab (Fig-
ure 1D) and is expressed much less in liver than in other
tissues (www.proteinatlas.org). Nevertheless, the unpaired
character of longer PPTs could also facilitate intramolec-
ular interactions with purine-rich regions, such as exons.
Interestingly, differential PU values between activated and
repressed homologs were present in the first ∼10-nt of the
exon (Supplementary Figure S10C) where U2AF35 bound
to a site-labelled pre-mRNA (4).
Younger, primate-specific exons tend to have weaker BPs
than established mammalian exons (45) and multiple BPs
have been associated with lower evolutionary conservation
than single BPs (59). In FYN, the U2AF-repressed exon 7a
is younger (118) and is preceded by a longer PPT than exon
7b (Table 1, Supplementary Figure S12). In U2AF1, both
conserved intronic regions are more diverse upstream of
exon 3 than exon Ab (Figure 3A), suggesting that the exon
with longer PPT also came second. However, the ancestral
origin of most U2AF-dependent exon pairs (Table 1) can-
not be established at present due to genome assembly un-
certainties in arthropods, multiple paralogs and high simi-
larities of duplicated regions (I.V., unpublished data and Pe-
ter Gunning, personal communication). In addition, a large
fraction of mutually exclusive homologous exons was ex-
pressed at very low levels in HEK293 cells or only had one
homolog in the mRNA, rendering most cases uninforma-
tive. Nevertheless, our results (Figures 1, 2, 5, Supplemen-
tary Figure S8 and S12), the association of longer BP-3′ss
distances with exon skipping (45,57) and the existence of
distant BP outliers (119) indicate that the role of extended
PPTs in exon repression and evolution is more important
than previously anticipated and further challenge the view
that longer vertebrate PPTs always improve exon inclusion
over short PPTs.
Our data also show thatU2AF-related and SR(-like) pro-
teins are important components of evolutionary processes
that assimilated many exon duplication events for the bene-
fit of tissue-specific regulation (Figures 4 and 5, Supplemen-
tary Figures S10 and S13). The increase in inclusion of both
exons observed formostU2AF-regulated pairs in cells lack-
ing SRSF3 is difficult to explain by chance, as only ∼1% of
exons were affected by Srsf3 knockdown (72), or by a re-
duced export of two-exon mRNAs for NMD, as both the
endo- and exogenous transcripts were more abundant in de-
pleted cells than in controls (Figure 4D and Supplementary
Figure S10B). SRSF1-3 interact with U2AF35 in vivo (110)
and may contribute to the recruitment of U2AF by binding
to enhancers (120,121), suggesting that the observed associ-
ation reflects their physical contacts during spliceosome as-
sembly. The increase of U2AF1c at the expense of U2AF1a
upon SRSF3 knockdown (Figure 4D and E) also supports
differential binding to exon Ab/3-containing pre-mRNAs.
Among canonical SR proteins, Srsf3 bound to the largest
number of substrates, arguing against the ability of other
members of the SR family to compensate its loss, despite
Srsf3 binding to their NMD switch exons (71,72). A sim-
ple ‘BP accessibility model’ where SRSF3 binding to the
BP region promotes exon Ab activation does not appear to
apply to Tpm1 (Supplementary Figure S10E). Instead, we
propose a model (Figure 5A) in which single-stranded, ex-
tended PPTs of repressed homologs attract multiple com-
plexes that compete not only for binding to RNA but
also for U2AF-interacting U2 snRNP components, such as
SF3B1, SF3A1 or SF3B3 (122). This concept is supported
by previous studies showing that SR proteins can promote
both exon inclusion and skipping, but their RNA binding
patterns or positional effects do not explain such opposite
responses (123).
Proper folding of primary transcripts is pivotal to en-
sure accurate exon recognition from viruses to humans
(100,124–126), but the relative importance of RNA folding
for splicing decisions is likely to vary in evolution. Long
single strands of nucleic acids reassociate orders of mag-
nitude slower than short oligonucleotides (127), and func-
tional long-range intramolecular contacts may be generally
less accessible in protein-rich vertebrates than in inverte-
brates. This may help explain the lack of splicing effects ob-
served for mutations of the longest inverted repeats in the
two conserved regions upstream of exons Ab/3, which are
highly reminiscent of the selector/docking sites in insects
(Supplementary Figure S9). Even if the selector/docking
site arrangement is inconsequential in species with a high di-
versity of proteins involved in structural RNA remodelling
such as humans, the reliance of splicing on appropriate local
folding has remained critical (Figure 3C, E and F) (51,124–
126,128).
Finally, we show that the higher expression of U2AF35b
than U2AF35a is U2AF65-dependent and requires interac-
tions between U2AF65 and the 2/6 helices of U2AF35
(Figures 6, and 7). Dimorphic amino acid positions 59,
61, 65 and 66 in the human UHM (Figure 4A) are in or
close to the 2 helix (22,23), yet UHMa and UHMb alone
did not recapitulate the differential expression of full-length
U2AF35 proteins unless the 6 helix was present (Figure
7B–F). Speculatively, alternative splicing of U2AF1 could
control the orientation of parallel 2/6 helices in U2AF35
isoforms, provide a means of generating distinct interac-
tions for the negatively charged 2 and affect chaperone
activities of U2AF65. The expression of U2AF35 proteins
was also differentially affected by ZF1 and ZF2 (Figure
7), confirming that the two ZFs are not equivalent (129),
as shown for other proteins with C3H ZFs. For example,
ZF1 targeted PIE-1 for degradation in somatic blastomers
whereas ZF2 to RNA-rich P granules (130). In the absence
of RNA, tristetraprolin ZF1, but not ZF2, adopted a stable
fold (131). Together with ZRSR2 and U2AF26, U2AF35
isoforms are unique among proteins with two C3H ZFs
in that these ZFs are not strictly in tandem arrangement
but are separated by the large UHM, providing an exciting
paradigm for future structural studies of these domains and
their RNA targets in the context ofU2- andU12-dependent
splicing.
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